News Summary:
MUSI-CO is testing the MINDKESTRA biofeedback method as a music therapy clinical protocol at St. Stefano Hospital in Prato, hypothesizing on May 19, 2026, that precisely designed, continuously measured, and ethically governed sound can serve as an active component of care. Previously, on May 13, 2026, the world's first lightweight, high-resolution CO₂ and CH₄ point source detector named "MUSICO" arrived at the Tiangong Space Station via Tianzhou-10. This detector, part of an HKUST-led project, marked Hong Kong’s inaugural scientific payload on the national space station. Earlier, on May 7, 2026, the company discussed the "paradoxes of AI music," advocating for a MIDI-first, human-centered music generation approach as the "only honest path forward" compared to platforms like Suno. This followed a February 17, 2026 usability test for GenLooper, which explored closing the gap between "random generation" and "human intent" in AI-assisted composition using a specialized classical MIDI dataset. The company initially introduced GEnLooper on November 22, 2025, as a generative MIDI instrument and VST plug-in designed to expand human musical agency, embodying MUSI-CO’s "open human-centric handmade-AI philosophy" and commitment to ethical AI design.
Subscribe for full access to Musico's profile